'Dangerous Drugs' Category
By Simmons Hanly Conroy | March 19, 2012
Faulty Hip Implants Can Cause Issues Even After Removal
Simmons Hanly Conroy is no longer accepting Hip Replacements cases. A February 2, 2012 article entitled, “Faulty hip implants may cause long-term health, joint damage,” by Janice Lloyd, published on yourlife.usatoday.com, reports… Read More
By Simmons Hanly Conroy | March 6, 2012
Qnexa: Should A Weight Loss Drug with Topamax and Phentermine Get Approval Before Testing? Consumer Reports Weighs In
A ConsumerReports.org article disagrees with experts who recently voted in an overwhelming majority that the Food and Drug Administration should approve the weight loss drug Qnexa and postpone important studies to monitor it for… Read More
By Simmons Hanly Conroy | January 27, 2012
All FDA Committee Members Should Get to Speak Out Regarding Yaz
In a previous blog post, we shared a news story regarding the FDA and the recent Yaz, Yasmin vote that has come under scrutiny. Is the FDA in bed with big pharmaceutical companies?… Read More
By Simmons Hanly Conroy | January 20, 2012
FDA’s Recent Yaz, Yasmin Vote Under Scrutiny
A recent MedPage Today article printed in EveryDay Health* reports that four FDA medical advisors voting on the risks versus benefits of birth control medications, like Yaz and Yasmin, had ties to Bayer. These FDA… Read More
By Simmons Hanly Conroy | November 3, 2011
Yaz Causes More Harm Than Good
The FDA recently released the results of their long-expected study on contraceptives containing drospirenone. It confirmed that women who take contraceptives such as Yaz are 75 percent more likely to suffer serious side effects… Read More
By Simmons Hanly Conroy | October 11, 2011
Avandia Revised Warning Not Adequate, Court Rules
A federal court has agreed with plaintiff’s counsel in a recent ruling that warnings about the dangers of Avandia, a drug used to help manage Type II Diabetes, may have been inadequate, according… Read More
By Simmons Hanly Conroy | June 3, 2011
FDA to Review Popular Birth Control Pill Yaz
Women who take birth control know doing so comes with a risk of blood clots, especially if they’re a smoker over 35. However, two new studies by the British Medical Journal found that women… Read More
By Simmons Hanly Conroy | June 1, 2011
Health Risks Underestimated for Popular Smoking-Cessation Drug Chantix
A Pharmaceutical watch dog group has reported that the risks of smoking cessation drug Chantix (Varenicline) have been underestimated in the latest round of the Food & Drug Administration reporting. The Institute for… Read More
By Simmons Hanly Conroy | May 24, 2011
Avandia Pulled From Shelves Months After Dangers Known
The Food & Drug Administration announced last week that it will pull the diabetes drug Avandia and its sister medications Avandamet and Avandaryl from retail pharmacy shelves beginning in November. After Nov. 18, only certified… Read More
By Simmons Hanly Conroy | April 27, 2011
Newer Birth Control Pills Like Yaz Aren’t Always Better
New studies find Yaz three times more likely to cause fatal blood clots, while reported deaths near 200 Yaz birth control is three times more likely to cause fatal blood clots than older, oral… Read More
